HaberlerTİBKM Kapsamında Üç Eser Daha TÜBA Tarafından Yayımlandı TÜBA-GEBİP Üyelerinden Önemli Buluş TÜBA’dan “Bilim ve Eğitim-Öğretim Dili Türkçe” Başlıklı Konferans ve Panel Andreas Tietze’nin “Tarihi ve Etmolojik Türkiye Türkçesi Lugati”nin Dört Cildi TÜBA Tarafından Yayımlandı TÜBA Üyelerine “TÜBİTAK 2017 Yılı Bilim ve Teşvik Ödülleri” TÜBA “TDUBAB -Uluslararası Hukuk, Diplomasi ve İş Birliği” Yaz Okulu Gerçekleştirildi TÜBA Başkanlığı 15 Temmuz Mesajı TÜBA “TDUBAB-Uluslararası Hukuk, Diplomasi ve İş Birliği” Yaz Okulu Düzenliyor TÜBA Uluslararası Akademi Ödülleri 2017 Aday Gösterme Süreci Devam Ediyor SETA’dan TÜBA Başkanı Prof. Acar’a Ziyaret
Great Support to TÜBA Council Member Prof. Şahin and His Team
Tarih: 09 OCAK 2017 Okunma Sayısı: 3858
Ministry of Development decided to support "R & D and Application Center on Cellular Therapies and Gene Therapies" project that will be carried out with the cooperation of TÜBA Council Member and Yeditepe University, Head of Department of Genetics and Bioengineering Prof. Fikrettin Şahin, Assoc. Prof. Gülderen Yanıkkaya Demirel from Yeditepe University, Faculty of Medicine and 10 assistant scientists.
With the project, "Yeditepe University Development and Application Center on Cellular Therapies and Gene Therapies Research, "is planned to develop new cellular therapies and gene therapies and to establish a genetic infrastructure for the purpose of carrying out studies to rapidly transfer newly developed products from the laboratory to the clinic.
For the first time in Turkey, cellular gene therapy products and protocols to be used in the treatment of cancer and many genetic diseases will be developed and produced in the laboratories planned to be established within the scope of the project. In addition, national and international preclinical and clinical phase studies of these products will be possible.
From this center, Yeditepe University Hospital and hospitals in Turkey and neighboring countries will be given cellular gene therapy products and services. The center will also be able to represent Turkey in many international R & D, preclinical and clinical studies.